LIGAND PHARMACEUTICALS INCORPORATED: net_income
| Value | {"amount": 52154000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | LIGAND PHARMACEUTICALS INCORPORATED |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:53:36.541691+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/27eb5961-32db-4e38-980e-0323d17c1b7b
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000886163-24-000009Retrieved: 2026-08-19T08:53:36.541691+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000886163/net-income/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/27eb5961-32db-4e38-980e-0323d17c1b7b
History
- no predecessors — first report